Aligning with this sales growth, Azotic™ will be “strongly EBITDA positive in 2023,” says Ray Chyc, CEO. “Our company has grown sales every year since we launched Envita in the USA in 2018. As we continue to add distributors across Europe, Africa, Central and South America, and Asia, we expect our growth to become both significant and dramatic in 2024 and beyond. We remain committed to building trust in our products and to working in partnership with global distribution channels to deliver our technology to growers. The science and performance of our product(s) are industry-leading, and with that, our sales around the globe are accelerating.”

Azotic’s unique nitrogen-fixing products are all based on the microbe Gluconocetobacter diazotrophicus (Gd), with initial work out of the University of Nottingham leading to the company’s formation in 2012. Covered by multiple patents globally, Gd, branded as Envita® and Encera™ across many regions of the world, works by setting up a symbiotic relationship with the plant, establishing itself within root, stem and leaf cells to fix nitrogen right inside the cell, making Envita/Encera one of the most efficient N-fixing microbes available commercially.

Read The Full Article Here – https://www.azotic.com/azotic-technologies-announces-expanded-global-growth/